---
figid: PMC7460598__ijms-21-05913-g004
figlink: pmc/articles/PMC7460598/figure/ijms-21-05913-f004/
number: Figure 4
caption: A proposed mechanism by which LOXL2 causes fibrosis and cardiac dysfunction.
  LOXL2 acts via the PI3K/AKT/mTOR pathway to activate TGF-β signaling and HIF-1 protein
  expression. GAL3 also activates TGF-β signaling, thus with possible similar effects
  as LOXL2. TGF-β signaling results in an increase in α-SMA, CTGF and LOXL2 expression,
  which leads to an increase in collagen deposition and cross-linking, resulting in
  fibrosis, ventricular stiffness and cardiac dysfunction. Inflammation causes an
  increase in NFκB which interacts with AP1 and Sp-1 proteins, also increasing LOXL2
  expression. Dysregulation of HIF-1 protein expression results in the disruption
  of oxygen homeostasis in the heart, also having pathological effects. Further investigation
  is needed to find out whether there is a direct interaction between LOXL2 and GAL3.
pmcid: PMC7460598
papertitle: Linking LOXL2 to Cardiac Interstitial Fibrosis.
reftext: Melisse Erasmus, et al. Int J Mol Sci. 2020 Aug;21(16):5913.
pmc_ranked_result_index: '40049'
pathway_score: 0.8953611
filename: ijms-21-05913-g004.jpg
figtitle: Proposed mechanism by which LOXL2 causes fibrosis and cardiac dysfunction
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7460598__ijms-21-05913-g004.html
  '@type': Dataset
  description: A proposed mechanism by which LOXL2 causes fibrosis and cardiac dysfunction.
    LOXL2 acts via the PI3K/AKT/mTOR pathway to activate TGF-β signaling and HIF-1
    protein expression. GAL3 also activates TGF-β signaling, thus with possible similar
    effects as LOXL2. TGF-β signaling results in an increase in α-SMA, CTGF and LOXL2
    expression, which leads to an increase in collagen deposition and cross-linking,
    resulting in fibrosis, ventricular stiffness and cardiac dysfunction. Inflammation
    causes an increase in NFκB which interacts with AP1 and Sp-1 proteins, also increasing
    LOXL2 expression. Dysregulation of HIF-1 protein expression results in the disruption
    of oxygen homeostasis in the heart, also having pathological effects. Further
    investigation is needed to find out whether there is a direct interaction between
    LOXL2 and GAL3.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LOXL2
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - SMAD3
  - SMAD2
  - FOS
  - FOSB
  - FOSL2
  - JUN
  - JUNB
  - FOSL1
  - JUND
  - AKT2
  - AKT3
  - AKT1
  - MTOR
  - TGFB1
  - TGFB2
  - TGFB3
  - CTGF
  - SETD2
  - Fibrosis
genes:
- word: LOXL2
  symbol: LOXL2
  source: hgnc_symbol
  hgnc_symbol: LOXL2
  entrez: '4017'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: SMAD2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: +AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: +AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: +AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: +AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: +AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: +AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: +AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: +TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: +TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: +TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: CTGF
  symbol: CTGF
  source: hgnc_symbol
  hgnc_symbol: CTGF
  entrez: '1490'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: LOXL2
  symbol: LOXL2
  source: hgnc_symbol
  hgnc_symbol: LOXL2
  entrez: '4017'
chemicals: []
diseases:
- word: Fibrosis
  source: MESH
  identifier: D005355
---
